BG

Bharatbhai Govindbhai Suthar

Active Director Director DIN 07766631
DIN 07766631 First appointment May 2018 Primary industry Pharma
Unlock full profile Investments · shareholding · contact details
Current companies 3 active board seats
Past companies 1 historical roles
Total affiliations 4 Since May 2018
Shareholding value •••• Premium profile

About Bharatbhai Govindbhai Suthar

Data last updated:

Bharatbhai Govindbhai Suthar is a Director at Flax Laboratories Private Limited (since 2023), Director at Kyana Labs Private Limited (since 2023) and Director at Enolic Pharma Private Limited (since 2025). The companies operate in Pharma, Paper and Healthcare. The 2 current companies with reported revenue have a combined latest revenue of ₹57.26 Cr; the largest is Flax Laboratories Private Limited at ₹52.86 Cr (FY 2025). Earlier, Bharatbhai Govindbhai Suthar was a Director at Linum Healthcare Private Limited (2018–2023).

DIN 07766631
Primary Designation Director
Industry Pharma
First Appointment 08 May 2018
Oldest Company Age 5 yrs
Largest company Flax Laboratories Private Limited · ₹52.86 Cr (FY 2025)
Combined revenue ₹57.26 Cr across 2 companies

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Flax Laboratories Private Limited U24239MH2021PTC359917
Director28 Jul 20232021₹52.86 Cr (FY 2025)Active
Kyana Labs Private Limited U21002GJ2023PTC139163
Director14 Mar 20232023₹4.40 Cr (FY 2025)Active
Enolic Pharma Private Limited U21001GJ2025PTC160339
Director18 Mar 20252025Active

Previous companies

CompanyDesignationAppointmentFoundedRevenueStatus
Linum Healthcare Private Limited U24117GJ2018PTC102221
Director08 May 20182018₹8.77 Cr (FY 2025)Active

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Kyana Labs Private Limited
Enolic Pharma Private Limited
Flax Laboratories Private Limited
Linum Healthcare Private Limited
Premium access

Shareholding and investment profile for Bharatbhai Govindbhai Suthar

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Bharatbhai Govindbhai Suthar

Bharatbhai Govindbhai Suthar currently holds 3 directorships: Flax Laboratories Private Limited (Director, since 28 Jul 2023, revenue ₹52.86 Cr (FY 2025)); Kyana Labs Private Limited (Director, since 14 Mar 2023, revenue ₹4.40 Cr (FY 2025)); Enolic Pharma Private Limited (Director, since 18 Mar 2025).

Bharatbhai Govindbhai Suthar was first appointed on 08 May 2018 as Director at Linum Healthcare Private Limited. The most recent appointment on record is 18 Mar 2025 at Enolic Pharma Private Limited.

The 2 current companies of Bharatbhai Govindbhai Suthar that report revenue have a combined latest revenue of ₹57.26 Cr: Flax Laboratories Private Limited ₹52.86 Cr (FY 2025); Kyana Labs Private Limited ₹4.40 Cr (FY 2025).

Bharatbhai Govindbhai Suthar held 1 earlier board appointment: Linum Healthcare Private Limited (Director, 08 May 2018 to 15 Feb 2023).

The current boards of Bharatbhai Govindbhai Suthar's companies include Abhaybhai Subodhbhai Maheta (Flax Laboratories Private Limited), Hetal Maheta Abhay (Flax Laboratories Private Limited), Kirti Dwarkadas Gaudani (Flax Laboratories Private Limited), Rajni Dwarkadas Gaudani (Flax Laboratories Private Limited), Rekhaben Bharatbhai Suthar (Flax Laboratories Private Limited), Nikita Nirav Shah (Enolic Pharma Private Limited), among others.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available